Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Gains from Investment Securities (2022 - 2025)

Historic Gains from Investment Securities for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $269000.0.

  • Orchestra BioMed Holdings' Gains from Investment Securities fell 6020.71% to $269000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 14375.94%. This contributed to the annual value of $1.2 million for FY2024, which is 30884.35% up from last year.
  • According to the latest figures from Q3 2025, Orchestra BioMed Holdings' Gains from Investment Securities is $269000.0, which was down 6020.71% from $428000.0 recorded in Q2 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Gains from Investment Securities ranged from a high of $1.0 million in Q2 2022 and a low of -$36000.0 during Q3 2022
  • For the 4-year period, Orchestra BioMed Holdings' Gains from Investment Securities averaged around $359925.0, with its median value being $323175.0 (2023).
  • As far as peak fluctuations go, Orchestra BioMed Holdings' Gains from Investment Securities tumbled by 10340.37% in 2024, and later soared by 361818.18% in 2025.
  • Orchestra BioMed Holdings' Gains from Investment Securities (Quarter) stood at $226000.0 in 2022, then soared by 43.0% to $323175.0 in 2023, then soared by 66.16% to $537000.0 in 2024, then plummeted by 49.91% to $269000.0 in 2025.
  • Its Gains from Investment Securities stands at $269000.0 for Q3 2025, versus $428000.0 for Q2 2025 and $387000.0 for Q1 2025.